Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.

According to early real-world data, the FDA-approved Evoque TTVR device is associated with positive outcomes when used to treat severe tricuspid regurgitation. 

An urgent device recall has been issued on Bravo CF, a line of pH capsules that are placed in the esophagus to aid in understanding the effects of acid reflux. Due to a dangerous manufacturing error, certain lots of the devices must be quarantined immediately.

The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.

The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.

Kenneth Margulies, MD, will be the group's next president. These new terms all begin after the HFSA Annual Scientific Meeting in September.

The historic procedure was performed in Texas on a 45-year-old patient who had been hospitalized for months with advanced heart failure.

A report from the Chartis Center for Rural Health warns that many hospitals in rural communities are at risk of closure if Medicaid cuts pass through Congress and are enacted by President Donald Trump. According to the analysis, women and newborns will disproportionately lose access to care.